Biotechnology major Biocon on Saturday (December 6, 2025) said it will fully integrate Biocon Biologics with itself, in a deal valuing the biologics unit at $5.5 billion. As part of the transaction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback